# A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers

> **NCT06840769** · PHASE1 · TERMINATED · sponsor: **Helsinn Healthcare SA** · enrollment: 50 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Fosnetupitant 235 mg solution
- **DRUG:** Akynzeo solution

## Key facts

- **NCT ID:** NCT06840769
- **Lead sponsor:** Helsinn Healthcare SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-06-17
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-23
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06840769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06840769, "A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06840769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*